Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAMIPRIL vs RASBURICASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAMIPRIL vs RASBURICASE: Safety Overview

Metric RAMIPRIL RASBURICASE
Total FAERS Reports 33,063 885
Deaths Reported 3,786 167
Death Rate 11.5% 18.9%
Hospitalizations 17,747 412
Average Patient Age 65.4 yrs 51.8 yrs
% Female Patients 53.1% 36.3%
FDA Approval Date Apr 15, 2014 N/A
Manufacturer GSMS, Incorporated Sanofi-Aventis U.S. LLC
Route ORAL N/A
Marketing Status Discontinued Prescription